Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business
  • Area funzionale
  • Data di pubblicazione Sort descending
Titolo di lavoro Site Posizione Divisione Business Area funzionale Data di pubblicazione Sort descending
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
P2P & T&E Specialist (Arabic Speaker) Selangor Malaysia Finance CTS Audit e finanza Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior MR Fuzhou (Fujian Province) Cina International Innovative Medicines I saldi Lug 05, 2024
Senior District Manager Zhanjiang (Guangdong Province) Cina International Innovative Medicines I saldi Lug 05, 2024
TME Profiling Head Office (Japan) (Pharmaceuticals) Giappone Biomedical Research Pharma Research Research & Development Lug 07, 2024
Specialist Resource Management Prague Repubblica Ceca Operations CTS Technology Transformation Lug 08, 2024
Automatisierungstechniker (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Lug 08, 2024
Associate Marketing Shanghai (Shanghai) Cina International Innovative Medicines Marketing Lug 08, 2024
Specialist, Master Batch Record (MBR) Design Millburn USA Operations CTS Technology Transformation Lug 09, 2024
Senior Global Program Regulatory Manager London (The Westworks) Regno Unito Development Innovative Medicines Research & Development Lug 09, 2024
Public Affairs Manager (m/f/d) Berlin West (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Communications & Public Affairs Lug 09, 2024
Clinical Development Medical Director - Immunology, Rheumatology East Hanover USA Development Innovative Medicines Research & Development Lug 09, 2024
Omnichannel Engagement Manager (m/w/d) Munich (Non-Sales Force) (Novartis Pharma GmbH) Germania International Innovative Medicines Marketing Lug 10, 2024
Associate Director Pipeline Management Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Lug 10, 2024
Japan Program Manager Head Office (Japan) (Pharmaceuticals) Giappone Development Innovative Medicines Research & Development Lug 10, 2024
Automatisierungsingenieur (m/w/d) Schaftenau Austria Operations Innovative Medicines Technical Operations Lug 10, 2024
Clinical Data Specialist II Hyderabad (Office) India Biomedical Research Research & Development Lug 10, 2024
Clinical Data Specialist I Hyderabad (Office) India Biomedical Research Research & Development Lug 10, 2024
Clinical Sciences Trial Leader Head Office (Japan) (Pharmaceuticals) Giappone Biomedical Research Pharma Research Research & Development Lug 10, 2024
Lead, RWE and Evidence Excellence Head Office (Japan) (Pharmaceuticals) Giappone International Innovative Medicines Research & Development Lug 10, 2024
Automatiker im Schichtbetrieb Stein Aargau Svizzera Operations Innovative Medicines Technical Operations Lug 11, 2024
Engineer (Project) Puurs Belgio Operations Innovative Medicines Technical Operations Lug 11, 2024
Associate Manager - MS&T Hyderabad (Office) India Operations Innovative Medicines Technical Operations Lug 11, 2024
RLT Analytical Product Project Leader (m/f/d) Ivrea Italia International Innovative Medicines Research & Development Lug 11, 2024
RLT Analytical Expert (m/f/d) Ivrea Italia International Innovative Medicines Research & Development Lug 11, 2024
RLT Drug Product Project Lead (m/f/d) Ivrea Italia International Innovative Medicines Research & Development Lug 11, 2024
Customer Engagement Manager Dermatology Amsterdam Paesi Bassi International Innovative Medicines I saldi Lug 12, 2024
Techniker (d/w/m) Schaftenau Austria Operations Innovative Medicines Technical Operations Lug 12, 2024
Cell and Gene Warehouse Specialist East Hanover USA Development Innovative Medicines Technical Operations Lug 12, 2024
Senior MR Wuhan (Hubei Province) Cina International Innovative Medicines I saldi Lug 12, 2024
Clinical Bioanalysis Monitor, PK Sciences (Principal Scientist) East Hanover USA Biomedical Research Pharma Research Research & Development Lug 14, 2024
Disease Area Specialist Israel Israele International Innovative Medicines I saldi Lug 15, 2024
Sr. Spec. IT Solution Delivery INSURGENTES Messico Operations CTS Tecnologia dell'informazione Lug 15, 2024
Medical Advisor Shanghai (Shanghai) Cina International Innovative Medicines Research & Development Lug 15, 2024
Global Program Clinical Head East Hanover USA Development Innovative Medicines Research & Development Lug 15, 2024
Global Program Head, Neuroscience East Hanover USA Development Innovative Medicines Research & Development Lug 16, 2024
Global Category Manager BT and MCE Governance APAC Hyderabad (Office) India Operations CTS procurement Lug 16, 2024
Sr.Specialist – Wireless Network Engineering INSURGENTES Messico Operations CTS Technology Transformation Lug 16, 2024
Network Specialist INSURGENTES Messico Operations CTS Technology Transformation Lug 16, 2024
Network Specialist INSURGENTES Messico Operations CTS Technology Transformation Lug 16, 2024
Specialist – Wireless Network Engineering INSURGENTES Messico Operations CTS Technology Transformation Lug 16, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • …
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia